The solutions to this issue most consistent with conservative principles are those that expand private capacity, reduce government as the exclusive bottleneck, and hold agencies accountable through transparent public reporting.

The primary driver of the increasing cost of health insurance coverage is the high price of health care, as opposed to high utilization of health care.

In order to address the growing shortage of health professionals in certain areas, Texas should expand APRN independent practice authority and pharmacist test-and-treat authority.

State policy should reflect the growing consensus that telehealth is a permanent delivery modality that must be supported, regulated, and reimbursed in a consistent and rational way.

Solutions to health care affordability lie in empowering consumers, increasing transparency, reducing mandates, and restoring competitive market forces rather than expanding government programs.

The existing system does not warrant sweeping, costly reforms, but targeted reinforcement, thorough oversight, and protection from reflexive regulatory expansion.

Reforming the federal program would deliver for patients, but the onus is on Washington to restore accountability and protect patients, employers, and taxpayers alike.

mRNA technology has the potential to combat infectious diseases, cancer, and rare genetic diseases by harnessing the body’s natural protein-making machinery.

Allowing pharmacists to “test and treat” for common acute conditions can improve health care access in spite of the primary care shortage.

TCCRI is pleased to release its latest white paper on the need to reform the 340B Program. Below is a one-pager document outlining the issues the paper discusses in detail. Read the one pager in the link above.